EFFICACY
Clinical trials for EFFICACY explained in plain language.
Never miss a new study
Get alerted when new EFFICACY trials appear
Sign up with your email to follow new studies for EFFICACY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Grown nerve cells injected into spinal cords in pioneering trial
Disease control Recruiting nowThis early-stage trial is testing whether injecting lab-grown nerve cells into the spinal cord is safe for people with a recent spinal cord injury. Researchers will enroll 12 participants who were injured 2 to 8 weeks ago to receive the experimental cell therapy. The main goal is…
Matched conditions: EFFICACY
Phase: PHASE1 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New cancer drug enters human testing for advanced solid tumors
Disease control Recruiting nowThis early-stage study is testing a new drug called HY07121 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose, check for side effects, and see if the drug shows any early signs of shrinking tumors. The…
Matched conditions: EFFICACY
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Doctors test 'Miracle' birth fluid stem cells on agonizing skin disease
Disease control Recruiting nowThis early-stage study is testing whether stem cells taken from amniotic fluid can help heal the extremely painful and dangerous skin wounds caused by calciphylaxis, a rare complication of kidney disease. Nine adult patients with calciphylaxis will receive the stem cell treatment…
Matched conditions: EFFICACY
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for tough cancers: testing a targeted drug
Disease control Recruiting nowThis study is testing a new drug, HYP-2090PTSA, for people with advanced solid tumors that have a specific genetic change called a KRAS mutation. The first part aims to find a safe and effective dose. The second part will explore how well the drug works for certain cancers with a…
Matched conditions: EFFICACY
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Can new glasses stop Kids' eyesight from getting worse?
Disease control Recruiting nowThis study is testing two new designs of eyeglass lenses to see if they can slow down how quickly nearsightedness (myopia) gets worse in children. About 120 kids, aged 6 to 14, will wear one of the two lens types daily for a year and have regular eye check-ups. The main goal is t…
Matched conditions: EFFICACY
Phase: NA • Sponsor: Beijing Tongren Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Doctors test new, more comfortable wrist entry for heart scans
Knowledge-focused Recruiting nowThis study is creating a registry to observe the safety and success of a newer technique for accessing arteries in the wrist during heart procedures. It will enroll 3,600 adults who need a heart scan or intervention and have a suitable artery. The goal is to gather real-world dat…
Matched conditions: EFFICACY
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:29 UTC